Health Affairs January 14, 2025
Eli Y. Adashi, Daniel P. O’Mahony, I. Glenn Cohen

On November 1, 2023, a contingent of 25 US state attorneys general wrote to the commissioner of the Food and Drug Administration (FDA) to encourage the agency “to act with urgency to address the inaccuracy of pulse oximetry when used on people with darker toned skin.” Pulse oximeters measure the amount of light that passes through the skin as a way to estimate how much oxygen is in a patient’s red blood cells. Melanin, which absorbs light that passes through the skin, can interfere with the pulse oximeter’s ability to accurately measure blood oxygen levels; inaccurate readings may contribute to misdiagnoses and worse clinical outcomes.

The state attorneys general made special note of the fact that their letter was...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices, States
Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO
Device industry scrambles as FDA job cuts cause delays
Device industry scrambles amid concern FDA layoffs will cause delays
Pharma and medtech industry reacts to FDA, CDC and NIH job cuts
Avante appoints new CEO under Staple Street ownership

Share This Article